0001179110-19-011133.txt : 20191021 0001179110-19-011133.hdr.sgml : 20191021 20191021161823 ACCESSION NUMBER: 0001179110-19-011133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191017 FILED AS OF DATE: 20191021 DATE AS OF CHANGE: 20191021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTSON MICHELLE CENTRAL INDEX KEY: 0001755098 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 191159752 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2019-10-17 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001755098 ROBERTSON MICHELLE C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Stock 2019-10-17 4 M 0 9750 A 16551 D Common Stock 2019-10-18 4 S 0 2936 13.83 D 13615 D Restricted Stock Units 2019-10-17 4 M 0 9750 0 D Common Stock 9750 29250 D Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Restricted Stock Units convert into common stock on a one-for-one basis. Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. /s/ R. Mark Chamberlin as attorney in fact 2019-10-21